Haisco Pharmaceutical Group

A ballpoint pen rests on top of a stack of documents ready for signing

Biotech

Lilly locks in vague, 5-program pact with Haisco worth up to $3B

Within hours of securing a gastrointestinal drug from Korea’s Hanmi, Lilly has ramped up the biobucks for a wider-ranging pact with China’s Haisco.

James Waldron Jun 1, 2026 7:26am

Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together

AbbVie inks $745M deal with China’s Haisco for two pain assets

Apr 13, 2026 9:48am

China export industry and global supply chain Cargo airplane flying over logistic containers

AirNexis swoops in with $200M series A for COPD asset

Jan 9, 2026 11:01am